Coronary heart disease in China
暂无分享,去创建一个
[1] Y. Li,et al. CHD and its risk factors in the People's Republic of China. , 1990, International journal of epidemiology.
[2] R. Collins,et al. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.
[3] Jing Liu,et al. Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.
[4] A data analysis of the Third National Coronary Intervention Registry , 2002 .
[5] M. Woodward,et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. , 2003, Diabetes care.
[6] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[7] Jun Zhu,et al. [Clinical characteristics and management of patients with ST segment elevation myocardial infarction in China: survey of 7510 cases]. , 2005, Zhonghua yi xue za zhi.
[8] Main Causes and Its Modifiable Risks of Death among Men and Women in China , 2006 .
[9] Yang-feng Wu,et al. Effect of Xuezhikang on Cardiovascular Events and Mortality in Elderly Patients with a History of Myocardial Infarction: A Subgroup Analysis of Elderly Subjects from the China Coronary Secondary Prevention Study , 2007, Journal of the American Geriatrics Society.
[10] Ling Liu,et al. Xuezhikang, An Extract of Cholestin, Reduces Cardiovascular Events in Type 2 Diabetes Patients With Coronary Heart Disease: Subgroup Analysis of Patients With Type 2 Diabetes From China Coronary Secondary Prevention Study (CCSPS) , 2007, Journal of cardiovascular pharmacology.